Alvotech Reports Record Results for 2024 and Provides Business Update
Provided By GlobeNewswire
Last update: Mar 26, 2025
Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for full year 2024 and provided a summary of recent pipeline and corporate highlights. Management will conduct a business update conference call and live webcast on March 27, 2024, at 8:00 am ET (12:00 pm GMT).
Read more at globenewswire.com
